°øÁö»çÇ×
HOME > °Ô½ÃÆÇ > °øÁö»çÇ×



Á¦¸ñ    Á¦5ȸ Çѱ¹ºÎÀξÏÀç´Ü ½ÉÆ÷Áö¿ò-The 1st Seoul International Sy
³¯Â¥ 2005-08-17 Á¶È¸¼ö 3952 ÆÄÀÏ [È­ÀϾøÀ½]

The 1st International Symposium on Papillomavirus
- Recent Trends in Research, Development, Clinical Practice and Evaluation Technology -
(The 5th Annual Symposium of Korean Gynecologic Cancer Foundation)
Jointly Organized by Korean Gynecologic Cancer Foundation/Korea Food & Drug AdministrationSeoul, Korea, 4 - 5 September, 2005
Agenda
Moderator : Dr. Sue Nie Park (KFDA)
Sep. 04, 2005 (Sunday)
 
Auditorium at Clinical Research Institute
(Seoul National Univ. Hospital)
 
08:30 - 09:00Registration
Prof. Jae Weon Kim (KGCF) & Ms. Soon Nam Kim (KFDA)
09:00 - 09:10 Opening Address
Prof. Hyo Pyo Lee (President, KGCF)
09:10 - 09:20 Welcoming Remarks
Dr. Chung Sook Kim (Commissioner, KFDA
09:20 - 09:30 Congratulatory Remarks I
Prof. Sung Ro Chung (Chief Director, KSOG)
09:30 - 09:40 Congratulatory Remarks II
Prof.. Gil-Ja Jhon (Director General, NIS-WIST)
 
PLENARY SESSION: Recent Progress in Researches on Papillomavirus Infection
Chair: Prof. Jae-Wook Kim (Yonsei Univ. College of Medicine)Prof. Kuy Wan Lee (Korea Univ.)
 
09:40 - 10:20 Plenary Talk (I)
Papillomavirus and Diseases
Dr. John T. Schiller (NCI, NIH, USA)
10:20 - 11:00 Plenary Talk (II)
The Role of HPV Variants and Hereditary Factors in Cervical Cancer
Prof. Yong Sang Song (Seoul National Univ.)
11:00 - 11:10Coffee break
 
SESSION I. Current Status of Papillomavirus Drug Development
Chair: Dr. Won Shin (KFDA)
Prof. Kyung Tai
11:10 - 11:40 Papillomavirus and Therapeutics including Therapeutic Vaccine
Dr. Thomas Jonathan Chambers (MSD, USA)
11:40 - 12:10HPV Vaccine Research in Korea
Dr. Haryoung Poo (KRIBB)
12:10 - 12:40 Considerations and Validation of HCII HPV DNA for Cervical Cancer Screening.
Mr. Mark Van Asten (Digene Inc., Australia)
12:40 - 14:00 Lunch
 
SESSION II. International Practice Trends on Clinical Utility of HPV DNA Test in Clinical Management
Chair: Dr. Yeowon Sohn (KFDA)
Prof. Joo-Hyun Nam (Ulsan Univ.)
 
14:00 - 14:30 Australian Case Study
Prof. Suzanne Garland (Royal Women’s Hospital, Australia)
14:30 - 15:00 China Case Study
Prof. You-Lin Qiao (Peking Union Medical College, China)
15:00 - 15:30 Korean Case Study
Prof. Jong Sup Park (Catholic Univ.)
15:30 - 15:50Coffee break
 
SESSION III. Innovative Strategy of National Regulatory Authorities
Chair: Dr. Sook Jin Hur (KFDA)
Prof. Ho Suk Suh (Korea Univ.)
 
15:50 - 16:20 Accreditation of WHO Global Laboratory Network and WHO International Reference Reagents
Dr. Sue Nie Park (KFDA)
16:20 - 16:50 Establishment of Korean National References
Prof. Joo Sung Yang (SungKyunGwan Univ..)
16:50 - 17:20 Establishment of Neutralizing Antibody Assay Methodology for Standardizing Efficacy Tests and Current Status of Establishing HPV VLP References
Prof. Hong Jin Kim (ChoongAng Univ..)
 
Concluding Remarks
 
17:20 - 17:30 Remarks by Director General, DBE
Dr. Hong Ki Min (KFDA)
18:00 - 21:00 Reception
 

Sep.. 5, 2005 (Monday)
Satellite Meeting to the 1st International Symposium on PapillomavirusInternational Meeting Room (DBE Building, KFDA)

 
Program
 
09:30 - 09:40 Opening Remarks
Dr. Hong Ki Min (KFDA)
 
SESSION (9:40 – 12:00)
Vision on Papillomavirus Drug Production and Development: Chance and Risk for Vaccine and Other Drugs
Chair : Dr. Seung Hwa Hong (KFDA)
 
09:40-10:10 Dr. John T. Schiller (NCI, NIH, USA)
10:10-10:40 Dr. Thomas Jonathan Chambers (MSD, USA)
 
Panelists :
Dr. Chung Keel Lee (KFDA)
Dr. Suzanne Garland (Royal Women’s Hospital, Australia)
Dr. You-Lin Qiao (Peking Union Medical College, China)
Dr. Jeong Jin Lee (LG-Life Sciences, Ltd.)
 
12:00 - 13:30 Lunch
 
Âü°¡ µî·Ï½Åû¼­ ´Ù¿î·Îµå


03080 ¼­¿ï½Ã Á¾·Î±¸ ´ëÇзΠ101 ¼­¿ï´ëÇб³º´¿ø º»°ü 11626È£

TEL : 02-2072-3143 / E-mail : kgcf@daum.net

Copyright (c) Çѱ¹ºÎÀξÏÀç´Ü All right reserved